Maria J. Tunon
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications.
Journal: Clinical and molecular hepatology
Published: November 28, 2022
Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation.
Journal: Acta pharmacologica Sinica
Published: July 21, 2022
Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence.
Journal: Journal of cellular physiology
Published: February 21, 2022
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Journal: Autophagy
Published: February 26, 2021
Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review.
Journal: Antioxidants (Basel, Switzerland)
Published: December 21, 2020
Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral-induced fulminant hepatic failure.
Journal: Journal of cellular and molecular medicine
Published: March 13, 2020
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review.
Journal: Nutrients
Published: October 21, 2019
Author Correction: The wide utility of rabbits as models of human diseases.
Journal: Experimental & molecular medicine
Published: July 05, 2019
Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl4-Induced Fibrosis and Human Hepatic Stellate Cells.
Journal: Frontiers in pharmacology
Published: March 21, 2018
Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma.
Journal: Journal of pineal research
Published: January 17, 2018
Last Updated: 09/26/2026